Júlia Saura

ORCID: 0009-0008-4566-7294
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Stroke Rehabilitation and Recovery
  • Venous Thromboembolism Diagnosis and Management
  • Autoimmune Neurological Disorders and Treatments
  • Peripheral Neuropathies and Disorders
  • Multiple Myeloma Research and Treatments
  • Genetic Neurodegenerative Diseases
  • Peripheral Artery Disease Management
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Cerebrovascular and Carotid Artery Diseases
  • Child Nutrition and Feeding Issues
  • Spine and Intervertebral Disc Pathology
  • Infant Health and Development
  • Glycogen Storage Diseases and Myoclonus
  • Prion Diseases and Protein Misfolding
  • Cancer Treatment and Pharmacology
  • Neurosurgical Procedures and Complications
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Healthcare Systems and Practices
  • Breastfeeding Practices and Influences

Hospital Clínic de Barcelona
2025

Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
2024

Clinical Trial Investigators
2023

Althaia
2014-2018

Hospital Sant Joan de Déu Barcelona
2013

Whether intravenous thrombolysis adds a further benefit when given before endovascular thrombectomy (EVT) is unknown. Furthermore, delays time to groin puncture, mainly among drip and ship patients.Using region-wide registry data, we selected cases that received direct EVT or combined thrombolysis+EVT for anterior circulation strokes between January 2011 October 2015. Treatment effect was estimated by stratification on propensity score. The average odds ratios the association of treatment...

10.1161/strokeaha.116.015857 article EN Stroke 2017-01-07

We sought to assess outcomes after endovascular treatment/therapy of acute ischemic stroke, overall and by subgroups, looked for predictors outcome.We used data from a mandatory, population-based registry that includes external monitoring completeness, which assesses reperfusion therapies consecutive patients with stroke since 2011. described subgroups (age ≤ or >80 years; onset-to-groin puncture >6 hours; anterior posterior strokes; previous IV recombinant tissue-type plasminogen activator...

10.1161/strokeaha.113.003489 article EN Stroke 2014-03-05

IMPORTANCE Creutzfeldt-Jakob disease (CJD) and autoimmune encephalitis with antibodies against neuronal surface antigens (NSA-abs) may present similar clinical features.Establishing the correct diagnosis has practical implications in management of care for these patients.OBJECTIVE To determine frequency NSA-abs cerebrospinal fluid patients suspected CJD pathologically confirmed (ie, definite) CJD. DESIGN, SETTING, AND PARTICIPANTSA mixed prospective (suspected) retrospective (definite)...

10.1001/jamaneurol.2013.4857 article EN JAMA Neurology 2013-11-18

Background and purpose Our aim was to revalidate the RACE scale, a prehospital tool that aims identify patients with large vessel occlusion (LVO), after its region-wide implementation in Catalonia, analyze geographical differences access endovascular treatment (EVT). Methods We used data from prospective CICAT registry (Stroke Code Catalan registry) includes all stroke code activations. The score evaluated by emergency medical services, time metrics, final diagnosis, presence of LVO, type...

10.1136/neurintsurg-2018-014519 article EN Journal of NeuroInterventional Surgery 2018-12-22

Background and Purpose— Since demonstration of the benefit endovascular treatment (EVT) in acute ischemic stroke patients with proximal arterial occlusion, care systems need to be reorganized deliver EVT a timely equitable way. We analyzed differences access by geographical areas Catalonia, territory highly decentralized model. Methods— studied 965 treated from prospective multicenter population-based registry reperfusion therapies Spain (SONIIA). Three different were defined: (A) health...

10.1161/strokeaha.116.013069 article EN Stroke 2016-04-01

Recent trials have shown the superiority of endovascular thrombectomy (EVT) over medical therapy alone in certain stroke patients with proximal arterial occlusion. Using data from Randomized Trial Revascularization With Solitaire FR Device Versus Best Medical Therapy Treatment Acute Stroke due to Anterior Circulation Large Vessel Occlusion Presenting Within 8-Hours Symptom Onset (REVASCAT) and a parallel reperfusion treatment registry, we sought assess utilization EVT defined patient...

10.1161/strokeaha.115.011050 article EN Stroke 2015-10-28

Abstract Background Functional capacity and emotional well-being decline more rapidly in individuals with congenital heart disease (CHD) compared to the general population. Although there is growing evidence that exercise training benefits these patients, few studies have assessed safety outcomes of multidisciplinary cardiac rehabilitation programs (CRPs) specifically designed for adults CHD. Purpose This study aimed evaluate effectiveness a CRP improving functional capacity, muscle...

10.1093/eurjpc/zwaf236.325 article EN European Journal of Preventive Cardiology 2025-05-01

<b><i>Background:</i></b> Among the acute ischemic stroke patients with large vessel occlusions and contraindications for use of IV thrombolysis, mainly on oral anticoagulation or presenting too late, primary endovascular therapy is often performed as an alternative to standard even though evidence supporting reperfusion therapies not yet established. Using different statistical approaches, we compared functional independence rates at 3 months among undergoing treated...

10.1159/000368433 article EN Cerebrovascular Diseases 2014-01-01

Objectives The aim of the study was to confirm safety and effectiveness using intravenous thrombolysis ( IVT ) with individuals aged 80 older in routine practice different hospital settings. Design Observasional registry. Setting Prospective multicenter population‐based registry acute stroke patients treated reperfusion therapies Catalonia, Spain (Sistema Online d'Informació de l'Ictus Agut). Participants Individuals only (N = 3,231; 1,189 (36.8%) ≥80). Measurements Symptomatic intracranial...

10.1111/jgs.14935 article EN Journal of the American Geriatrics Society 2017-06-02

Introduction: We aimed to revalidate the RACE scale as a pre-hospital tool identify patients with large vessel occlusion (LVO) and receiving endovascular treatment (EVT) after its implementation in Stroke Code protocol of Catalonia (7.5 M inhabitants). Methods: used data from CICAT registry (Feb Jun 2016), government-mandated, prospective, hospital-based dataset that includes all activations. is linked EMS database capture information about care. score, in-hospital delays, final diagnostic,...

10.1161/str.48.suppl_1.18 article EN Stroke 2017-02-01

10.1016/j.nrleng.2014.08.004 article EN publisher-specific-oa Neurología (English Edition) 2016-05-01

Background: Benefit of endovascular treatment (EVT) for acute stroke has been demonstrated recently in several randomized clinical trials. This benefit is time-dependent and revascularization achieved at later times associated with a poor risk-benefit ratio. Hypothesis: Stroke Code systems based on drip-and-ship model have implemented worldwide to accelerate iv-tPA treatment. However, access EVT remote areas hampered due long distances delays related inter-hospital transfers. Methods: We...

10.1161/str.47.suppl_1.wmp69 article EN Stroke 2016-02-01
Coming Soon ...